|
Nutrition and Exercise Prehabilitation in Patients Awaiting Liver Transplantation
RECRUITINGN/ASponsored by Kalliopi Anna Poulia
Actively Recruiting
PhaseN/A
SponsorKalliopi Anna Poulia
Started2026-01-08
Est. completion2028-07
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07561138
Summary
This study aims to evaluate the effects of a diet with even protein distribution plus exercise (Group A) versus a diet with skewed protein distribution plus exercise (Group B) versus standard dietary and physical activity advice (Group C) on nutritional status, body composition and functional status in patients awaiting liver transplantation.
Eligibility
Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria: * End-stage liver disease, diagnosed by transient elastography (FibroScan) or imaging-based evaluation with compatible clinical picture * Referred for liver transplantation and evaluated to have a high likelihood of being listed, according to primary hepatologist assessment, or already listed for liver transplantation * No prior formal dietary advice Exclusion Criteria: * Age \< 18 years old * Estimated waiting time for liver transplantation \< 3 months * Estimated life expectancy \< 3 months * Chronic kidney disease requiring protein restriction * Exercise contraindicated (e.g., active or recent variceal bleeding, severe grade of hepatic encephalopathy, refractory ascites, etc.) * Unstable or severe psychiatric disorder * Pregnancy or lactation * Inability to provide written informed consent
Conditions7
End Stage Liver DiseaseFrailtyLiver CirrhosisLiver DiseaseLiver TransplantationMalnutritionSarcopenia
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorKalliopi Anna Poulia
Started2026-01-08
Est. completion2028-07
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07561138